CoChat

Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors

Ozmenler, Nahit Kamil, Karlidere, Tunay, Bozkurt, Ali, Yetkin, Sinan, Doruk, Ali, Sutcigil, Levent, Cansever, Adnan, Uzun, Ozcan, Ozgen, Fuat, Ozsahin, Aytekin · 2008 · Human Psychopharmacology: Clinical and Experimental
Cited by 68

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: To evaluate the effect of mirtazapine augmentation in patients with sexual dysfunction induced by current selective serotonin reuptake inhibitor (SSRI) treatment. Methods: Forty‐nine outpatients in remission from major depressive disorder with SSRI treatment and experiencing treatment‐emergent sexual dysfunction were invited to participate and 33 (25 women and 8 men) were included in this 8‐week open‐label study. All patients continued her/his current SSRI treatment (dosages unchanged) and started on mirtazapine augmentation of 15 mg/day during the first week and 30 mg/day throughout the rest of the study. The Hamilton rating scale for depression (HAM‐D), the psychotropic‐related sexual dysfunction questionnaire (PRSexDQ), and the Golombok and Rust Inventory of Sexual Satisfaction (GRISS) were given to all patients at baseline and at each follow‐up (end of the first, second, fourth, sixth, and eight weeks). Results: Mirtazapine augmentation led to significant reductions in HAM‐D, PRSexDQ, and GRISS scores throughout the study especially after week 4 and 48.5% of patients (n = 16) reported that they had no overall sexual dysfunction at the end of the study. Conclusions: Mirtazapine augmentation is a good choice for the treatment of SSRI‐induced sexual dysfunction, and the results are typically seen later after 4–8 weeks. Copyright © 2008 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.929

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 68

Metadata

Authors
Ozmenler, N. K., Karlidere, T., Bozkurt, A., Yetkin, S., Doruk, A., Sutcigil, L., Cansever, A., Uzun, O., Ozgen, F., & Ozsahin, A.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2008-02-15
Volume
23
Issue
4
Pages
321-326
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2005537278
Cited by
68
References
4
FWCI
3.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.